Quadrant Capital Group LLC Zynex Inc Transaction History

Quadrant Capital Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$7.1 - $10.89 $2,463 - $3,778	347 Added 630.91%	402 $4,000
Q3 2023 Nov 14, 2023	SELL	$6.95 - $9.89 $792 - $1,127	-114 Reduced 67.46%	55 $0
Q2 2023 Aug 09, 2023	BUY	$8.59 - $14.56 $523 - $888	61 Added 56.48%	169 $1,000
Q1 2023 May 11, 2023	SELL	$9.53 - $16.8 $266 - $470	-28 Reduced 20.59%	108 $1,000
Q4 2022 Feb 10, 2023	BUY	$8.71 - $14.28 $243 - $399	28 Added 25.93%	136 $1,000
Q3 2022 Nov 10, 2022	SELL	$7.19 - $9.91 $2,725 - $3,755	-379 Reduced 77.82%	108 $1,000
Q2 2022 Aug 09, 2022	BUY	$5.78 - $8.87 $2,814 - $4,319	487 New	487 $4,000
Q4 2021 Feb 01, 2022	SELL	$8.71 - $13.77 $226 - $358	-26 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$10.35 - $15.65 $269 - $406	26 New	26 $0

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $293M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.